Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors: Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor

Digestive Surgery

Volumn 20, Issue 3, 2003, Pages 183-191

  Yasuoka, Rie ^a   Sakakura, Chohei ^a   Shimomura, Katsumi ^a   Fujita, Yoshifumi ^a   Nakanishi, Masayoshi ^a   Aragane, Hideki ^a   Hagiwara, Akeo ^a   Bamba, Masamichi ^b   Abe, Tatsuo ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Medical Care Center   (Japan)

Author keywords

c kit gene; Gastrointestinal mesenchymal tumor; Gastrointestinal stromal tumor; Myogenic tumor; Neurogenic tumor

Indexed keywords

ALPHA ACTIN; CD34 ANTIGEN; DNA; PROTEIN S 100; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; GENE AMPLIFICATION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MALE; MUSCLE TUMOR; NEUROGENIC TUMOR; ONCOGENE C KIT; POINT MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; EXONS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LEIOMYOMA; MALE; MESODERM; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, MUSCLE TISSUE; NEOPLASMS, NERVE TISSUE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; STROMAL CELLS;

EID: 0037679245     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070384     Document Type: Article

References (44)

1. Mazur MT, Clark HB: Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983;7:507-519.
2. Rosai J: Gastrointestinal tract. Stromal tumors; in Rosai J (ed): Ackerman's Surgical Pathology. St. Loius, Mosby,1996, pp 645-647.
3. Miettinen M, Virolainen M, Rikala MS: Gastrointestinal stromal tumors - value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 1995;19:207-216.
4. Ueyama T, Guo K, Hashimoto H, Daimaru Y, Enjoji M: A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992;69:947-955.
5. Chan JK: Mesenchymal tumors of the gastrointestinal tract: A paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implication of c-kit in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal diseases? Adv Anat Pathol 1999;6:19-40.
6. Tazawa K, Tsukuda K, Makuuchi H, Tsutsumi Y: An immunohistochemical and clinicopathological study of gastrointestinal stromal tumors. Pathol Int 1999;49:786-798.
7. Miettinen M, Sarlomo-Rikala M, Lasota J: Gastrointestinal stromal tumors: Recent advances in understanding of their biology. Hum Pathol 1999;30:1213-1220.
8. Graadt van Roggen JF, van Velthuysen ML, Hogendoorn PC: The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001;54:96-102.
9. Jeng YM, Mao TL, Hsu WM, Huang SF, Hsu HC: Congenital interstitial cell of Cajal hyperplasia with neuronal intestinal dysplasia. Am J Surg Pathol 2000;24:1568-1572.
10. Seldal T, Edvardsson H: Diagnosis of gastrointestinal stromal tumor by fine-needle aspiration biopsy: A cytological and immunocytochemical study. Diagn Cytopathol 2000;23:397-401.
11. Hoshino N, Murata T, Oka K, Kawakami K, Hoshino K, Sekoguchi S, Suga T, Nishimura A, Kato M, Hamada M: Gastrointestinal stromal tumors of the small intestine that expressed c-kit protein. Intern Med 2000;39:914-919.
12. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M: CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11:728-734.
13. Vliagoftis H, Worobec AS, Metcalfe DD: The proto-oncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol 1997;100:435-440.
14. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341-3351.
15. Williams DE, Eisenman J, Baird A, Rauch C, van Ness K, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of a ligand for the c-kit proto-oncogene. Cell 1990;63:167-174.
16. Zsebo KM, Williams DA, Geissler EN, Broudy WC, Martin FH, Atkins HL, Hsu R-Y, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattenach BM, Galli SJ, Suggs SV: Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:214-224.
17. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Tunio GM, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-580.
18. Nakahara M, Isozaki K, Hirota S, Miyagawa J, Hase-sawada N, Taniguchi M, Nishida T, Kanayama S, Kitamura Y, Shinomura Y, Matsuzawa Y: A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology 1998;115:1090-1095.
19. Hirota S, Isozaki K, Nishida T, Kitamura Y: Effect of loss-of-function and gain-of-function mutations of c-kit on the gastrointestinal tract. J Gastroenterol 2000;35:75-79.
20. Hirota S, Kitamura Y: Gain-of-function mutation of c-kit gene in human gastrointestinal stromal tumors. Mol Med 1997;34:698-704.
21. Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, Kitamura Y: Familial gastrointestinal stromal tumors with germline mutations of the KIT gene. Nat Genet 1998;19:323-324.
22. Sakurai S, Oguni S, Hironaka M, Fukuyama M, Morinaga S, Saito K: Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese. Jpn J Cancer Res 2001;92:494-498.
23. Lasota J, Wozniak A, Sarlomo-Rikala M, Rys J, Kordek R, Nassar A, Sobin LH, Miettinen M: Mutations in exons 9 and 13 of kit gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. Am J Pathol 2000;157:1091-1095.
24. Lux ML, Rubin BP, Biase TL, Chen CJ, Maclure T, Demetri G, Xiao S, Singer S, Fletcher CD, Fletcher JA: KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 2000;156:791-795.
25. Isozaki K, Terris B, Belghiti J, Schiffmann S, Hirota S, Vanderwinden JM: Germline-activating mutations in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol 2000;157:1581-1585.
26. Moskaluk CA, Tian Q, Marshall CR, Rumpel CA, Franquemont DW, Frierson HF Jr: Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene 1999;18:1897-1902.
27. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M: Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999;154:53-59.
28. Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O'Leary T: KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 1998;78:1633-1636.
29. Sakurai S, Fukusawa T, Chong JM, Tanaka A, Fukayama M: C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal). Jpn J Cancer Res 1999;90:1321-1328.
30. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y: Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999;59:4297-4300.
31. Miettinen M, Sarlomo-Rikala M, Lasota J: Gastrointestinal stromal tumors. Ann Chir Gynaecol 1998;87:278-281.
32. Nishida T, Hirota S: Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000;15:1293-1301.
33. Hanai J, Hoshida Y, Tsujii Y, Tatsuta M: Stromal tumor of the ileum. Arch Histopathol DD 1998;5:21-24.
34. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y: Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 1994;83:2619-2626.
35. Tsujimura T, Morimoto M, Hashimoto K, Moriyama Y, Kitayama H, Matsuzawa Y, Kitamura Y, Kanakura Y: Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. Blood 1996;87:273-283.
36. Miettinen M, Sarlomo-Rikala M, Lasota J: KIT expression in angiosarcomas and fetal endothelial cells: Lack of mutations of exon 11 and exon 17 of c-kit. Mod Pathol 2000;13:536-541.
37. Kimura H, Yonemura Y, Kadoya N, Kosaka T, Miwa K, Miyazaki I, Sawa T, Yoshimitsu S, Nishida Y, Kamata T, et al: Prognostic factors in primary gastrointestinal leiomyosarcoma. A retrospective study. World J Surg 1991;15:771-777.
38. Cunningham RE, Federspiel BH, McCarthy WF, Sobin LH, O'Leary TJ: Predicting prognosis of gastrointestinal smooth muscle tumors. Role of clinical and histologic evaluation, flow cytometry, and image cytometry. Am J Surg Pathol 1993;17:588-594.
39. Rudolph P, Gloeckner K, Parwaresch R, Harms D, Schmidt D: Immunophenotype, proliferation, DNA ploidy, and behavior of gastrointestinal stromal tumors: A multivariate clinicopathological study. Hum Pathol 1998;29:791-800.
40. Carrilo R, Candia A, Rodriguez-Peralto JL: Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 1997;28:160-165.
41. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58.
42. Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ: The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136:383-389.
43. Medina-Franco H, Eltoum IE, Urist MM, Heslin MJ: Primary gastrointestinal sarcomas. Am Surg 2000;66:1171-1175.
44. Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF: Gastrointestinal stromal tumors: Current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000;7:705-712.